Interaction of alkylphospholipid liposomes with MT-3 breast-cancer cells depends critically on cholesterol concentration

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 12, 2008, Pages 2682-2689

  Koklic, Tilen ^a   Zeisig, Reiner ^b   Šentjurc, Marjeta ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Alkylphospholipid; Breast cancer cell; Cholesterol; Electron paramagnetic resonance; Liposome; Liposome cell interaction; Membrane domain; Spin label

Indexed keywords

(1,1 DIMETHYLPIPERIDIN 1 IUM 4 YL)OCTADECYL PHOSPHATE; CHOLESTEROL; CHOLINE; LIPOSOME; PHOSPHOLIPID; TEMPOCHOLINE; UNCLASSIFIED DRUG;

ARTICLE; BILAYER MEMBRANE; BREAST CANCER; CANCER CELL CULTURE; CELL INTERACTION; ELECTRON SPIN RESONANCE; HUMAN; HUMAN CELL; MEMBRANE STRUCTURE; MICELLE; PRIORITY JOURNAL; SPIN LABELING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHOLESTEROL; CYCLIC N-OXIDES; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; HUMANS; LIPOSOMES; OXIDATION-REDUCTION; PHOSPHOLIPIDS; SPIN LABELS;

EID: 55749103874     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.08.024     Document Type: Article

References (41)

1. Vink S.R., van Blitterswijk W.J., Schellens J.H.M., and Verheij M. Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy. Cancer Treat. Rev. 33 (2007) 191-202
2. Mollinedo F. Antitumour ether liquids: proapoptotic agents with multiple therapeutic indications. Expert Opin. Ther. Pat. 17 (2007) 385-405
3. Zeisig R., Arndt D., Stahn R., and Fichtner I. Physical properties and pharmacological activity in vitro and in vivo of optimised liposomes prepared from a new cancerostatic alkylphospholipid. Biochim. Biophys Acta, Biomembr. 1414 (1998) 238-248
4. Fichtner I., Zeisig R., Naundorf H., Jungmann S., Arndt D., Asongwe G., Double J.A., and Bibby M.C. Antineoplastic activity of Allkylphosphocholines (Apc) in human breast carcinomas in-vivo and in-vitro - use of liposomes. Breast Cancer Res. Treat. 32 (1994) 269-279
5. Zeisig R., Fichtner I., Arndt D., and Jungmann S. Antitumor effects of alkylphosphocholines in different murine tumor-models - use of liposomal preparations. Anti-Cancer Drugs 2 (1991) 411-417
6. Zeisig R., Müller K., Maurer N., Arndt D., and Fahr A. The composition-dependent presence of free (micellar) alkylphospholipid in liposomal formulations of octadecyl-1,1-dimethyl-piperidino-4-yl-phosphate affects its cytotoxic activity in vitro. J. Membr. Biol. 182 (2001) 61-69
7. Abramović Z., Šuštaršič K., Teskač K., Šentjurc M., and Kristl J. Influence of nanosized carriers with benzyl nicotinate and penetration enhancers on skin oxygenation. Int. J. Pharm. 359 (2008) 220-227
8. Swartz H.M., Sentjurc M., and Morse II P.D. Cellular metabolism of water-soluble nitroxides: effect on rate of reduction of cell/nitroxide ratio, oxygen concentrations and permeability of nitroxides. Biochim. Biophys. Acta 888 (1986) 82-90
9. Ueda A., Nagase S., Yokoyama H., Tada M., Noda H., Ohya H., Kamada H., Hirayama A., and Koyama A. Importance of renal mitochondria in the reduction of TEMPOL, a nitroxide radical. Mol. Cell. Biochem. 244 (2003) 119-124
10. Koklic T., Sentjurc M., and Zeisig R. The influence of cholesterol and charge on the membrane domains of alkylphospholipid liposomes as studied by EPR. J.Liposome Res. 12 (2002) 335-352
11. Pabst G., Hodzic A., Strancar J., Danner S., Rappolt M., and Laggner P. Rigidification of neutral lipid bilayers in the presence of salts. Biophys. J. 93 (2007) 2688-2696
12. Stopar D., Strancar J., Spruijt R.B., and Hemminga M.A. Motional restrictions of membrane proteins: a site-directed spin labeling study. Biophys. J. 91 (2006) 3341-3348
13. Strancar J., Koklic T., and Arsov Z. Soft picture of lateral heterogeneity in biomembranes. J. Membr. Biol. 196 (2003) 135-146
14. Strancar J., Koklic T., Arsov Z., Filipic B., Stopar D., and Hemminga M.A. Spin label EPR-based characterization of biosystem complexity. J. Chem. Info. Model. 45 (2005) 394-406
15. Lasic D.D. Liposomes: From Physics to Applications (1993), Elsevier, Amsterdam-London-New York-Tokyo
16. Zeisig R., Eue I., Kosch M., Fichtner I., and Arndt D. Preparation and properties of sterically stabilized hexadecylphosphocholine (miltefosine)-liposomes and influence of this modification on macrophage activation. Biochim. Biophys. Acta 1283 (1996) 177-184
17. Zeisig R., Arndt D., Stahn R., and Fichtner I. Physical properties and pharmacological activity in vitro and in vivo of optimised liposomes prepared from a new cancerostatic alkylphospholipid. Biochim. Biophys. Acta 1414 (1998) 238-248
18. Struck D.K., Hoekstra D., and Pagano R.E. Use of resonance energy-transfer to monitor membrane-fusion. Biochemistry 20 (1981) 4093-4099
19. Schindler H., and Seelig J. EPR spectra of spin labels in lipid bilayers. J. Chem. Phys. 59 (1973) 1841-1850
20. Strancar J., Sentjurc M., and Schara M. Fast and accurate characterization of biological membranes by EPR spectral simulations of nitroxides. J. Magn. Reson. 142 (2000) 254-265
21. Ge M.T., Field K.A., Aneja R., Holowka D., Baird B., and Freed J.H. Electron spin resonance characterization of liquid ordered phase of detergent-resistant membranes from RBL-2H3 cells. Biophys. J. 77 (1999) 925-933
22. Swamy M.J., Ciani L., Ge M.T., Smith A.K., Holowka D., Baird B., and Freed J.H. Coexisting domains in the plasma membranes of live cells characterized by spin-label ESR spectroscopy. Biophys. J. 90 (2006) 4452-4465
23. D.E. Budil, S. Lee S. Saxena, J.H. Freed, Nonlinear-least squares analysis of slow-motion epr spetra in one and two dimensions using a modified levenberg-marquardt algorithm, 120 (1996) 155.
24. Robinson B., Thomann H., Beth A.H., Fajer P., and Dalton L.R. The phenomenon of magnetic resonance: Theoretical considerations (1985), CRC Press, Boca Raton
25. Schneider D.J., and Freed J.H. Calculating slow motional magnetic resonance spectra: a user's guide (1989), Plenum Press, New York
26. Z. Arsov, J. Strancar, Determination of partition coefficient of spin probe between different lipid membrane phases, J. Chem. Inf. Model. ASAP Article (2005).
27. Filipič B., and Štrancar J. Tuning EPR spectral parameters with a genetic algorithm. Appl. Soft Comput. 1 (2001) 83
28. Strancar J., Koklic T., and Arsov Z. Soft picture of lateral heterogeneity in biomembranes. J Membr. Biol. 196 (2003) 135-146
29. Memoli A., Palermiti L.G., Travagli V., and Alhaique F. Effects of surfactants on the spectral behaviour of calcein (II): a method of evaluation. J. Pharm. Biomed. Anal. 19 (1999) 627-632
30. Swartz H.M., Sentjurc M., and Morse P.D. Cellular-metabolism of water-soluble nitroxides - effect on rate of reduction of cell nitroxide ratio, oxygen concentrations and permeability of nitroxides. Biochim. Biophys. Acta 888 (1986) 82-90
31. Swartz H.M., Šentjurc M., and Kocherginsky N. Metabolism of nitroxides and their products in cells, Nitroxide spin labels: Reaction in biology and chemistry (1995), CRC press, Boca Raton 113-146
32. Rhodes C.J. Electron spin resonance (some application for biological and environmental sciences). Annu. Rep. Prog. Chem., Sect. C: Phys. Chem. 100 (2004) 149-193
33. Kier A.B. Membrane-properties of metastatic and nonmetastatic cells cultured from C3h mice injected with Lm fibroblasts. Biochim. Biophys. Acta 1022 (1990) 365-372
34. Arsov Z., and Strancar J. Determination of partition coefficient of spin probe between different lipid membrane phases. J. Chem. Info. Model. 45 (2005) 1662-1671
35. Huang J., and Feigenson G.W. A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys. J. 76 (1999) 2142-2157
36. Chen K., Morse P.D., and Swartz H.M. Kinetics of enzyme-mediated reduction of lipid soluble nitroxide spin labels by living cells. Biochim. Biophys. Acta 943 (1988) 477-484
37. Sentjurc M., Morse P.D., and Swartz H.M. Influence of metabolic-inhibitors on the nitroxide reduction in the cells. Period. Biol. 88 (1986) 202-203
38. Daleke D.L., Hong K.L., and Papahadjopoulos D. Endocytosis of liposomes by macrophages - binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim. Biophys. Acta 1024 (1990) 352-366
39. Simoes S., Moreira J.N., Fonseca C., Duzgunes N., and de Lima M.C. On the formulation of pH-sensitive liposomes with long circulation times. Adv. Drug Deliv. Rev. 56 (2004) 947-965
40. Yoshimura T., Shono M., Imai K., and Hong K.L. Kinetic-Analysis of Endocytosis and Intracellular Fate of Liposomes in Single Macrophages. J. Biochem. 117 (1995) 34-41
41. Huang J.Y., Buboltz J.T., and Feigenson G.W. Maximum solubility of cholesterol in phosphatidylcholine and phosphatidylethanolamine bilayers. Biochim. Biophys Acta, Biomembr. 1417 (1999) 89-100